Adomeglivant
Modify Date: 2024-01-10 22:37:52
Adomeglivant structure
|
Common Name | Adomeglivant | ||
|---|---|---|---|---|
| CAS Number | 1488363-78-5 | Molecular Weight | 555.628 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 656.7±55.0 °C at 760 mmHg | |
| Molecular Formula | C32H36F3NO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 350.9±31.5 °C | |
Use of AdomeglivantAdomeglivant is a potent and selective glucagon receptor antagonist that is used in clinical trial for type 2 diabetes mellitus. |
| Name | Adomeglivant |
|---|---|
| Synonym | More Synonyms |
| Description | Adomeglivant is a potent and selective glucagon receptor antagonist that is used in clinical trial for type 2 diabetes mellitus. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 656.7±55.0 °C at 760 mmHg |
| Molecular Formula | C32H36F3NO4 |
| Molecular Weight | 555.628 |
| Flash Point | 350.9±31.5 °C |
| Exact Mass | 555.259644 |
| LogP | 7.53 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.542 |
| Storage condition | 2-8℃ |
| 3-(4-{(1S)-1-[(4'-tert-butyl-2,6-dimethylbiphenyl-4-yl)oxy]-4,4,4-trifluorobutyl}benzamido)propanoic acid |
| adomeglivant |
| UNII:74Z5ZL2KVG |
| 74Z5ZL2KVG |
| β-Alanine, N-[4-[(1S)-1-[[4'-(1,1-dimethylethyl)-2,6-dimethyl[1,1'-biphenyl]-4-yl]oxy]-4,4,4-trifluorobutyl]benzoyl]- |
| N-{4-[(1S)-1-{[2,6-Dimethyl-4'-(2-methyl-2-propanyl)-4-biphenylyl]oxy}-4,4,4-trifluorobutyl]benzoyl}-β-alanine |
| LY2409021 |
| UNII-74Z5ZL2KVG |